Anthony G. Fenech

Imsida, Malta

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

A Maltese Study in Determining the Presence of Chronic Obstructive Pulmonary Disease in Metabolic Syndrome.

A Maltese Study in Determining the Presence of Chronic Obstructive Pulmonary Disease in Metabolic Syndrome.

Journal: International journal of chronic obstructive pulmonary disease

Published: March 12, 2026

GLP-1 receptor agonist safety in a perioperative setting: more questions than answers.

GLP-1 receptor agonist safety in a perioperative setting: more questions than answers.

Journal: Expert review of clinical pharmacology

Published: January 22, 2026

Chronic Obstructive Pulmonary Disease and Metabolic Syndrome: A Maltese Study on Biomarkers and Clinical Implications.

Chronic Obstructive Pulmonary Disease and Metabolic Syndrome: A Maltese Study on Biomarkers and Clinical Implications.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy

Published: December 31, 2024

3D cell culture models in research: applications to lung cancer pharmacology.

3D cell culture models in research: applications to lung cancer pharmacology.

Journal: Frontiers in pharmacology

Published: May 24, 2024

Substitution of histidine 30 by asparagine in manganese superoxide dismutase alters biophysical properties and supports proliferation in a K562 leukemia cell line.

Substitution of histidine 30 by asparagine in manganese superoxide dismutase alters biophysical properties and supports proliferation in a K562 leukemia cell line.

Journal: European biophysics journal : EBJ

Published: September 29, 2020

Ethical aspects pertaining to the use of pharmacogenetic tests.

Ethical aspects pertaining to the use of pharmacogenetic tests.

Journal: Research in social & administrative pharmacy : RSAP

Published: May 11, 2020

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.

Journal: PloS one

Published: February 17, 2017

Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.

Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.

Journal: Nature genetics

Published: July 15, 2016

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.

Journal: PloS one

Published: April 14, 2016

Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.

Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: March 22, 2016

The effect of turmeric (Curcumin) supplementation on cytokine and inflammatory marker responses following 2 hours of endurance cycling.

The effect of turmeric (Curcumin) supplementation on cytokine and inflammatory marker responses following 2 hours of endurance cycling.

Journal: Journal of the International Society of Sports Nutrition

Published: August 12, 2014

Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720.

Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720.

Journal: The EPMA journal

Published: December 13, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026